Correlation of polymorphisms of interleukin-2 gene and HBV DNA copies in patients with chronic hepatitis B / 中华肝脏病杂志

<p><b>OBJECTIVE</b>To investigate the relationships of polymorphisms of interleukin-2 (IL-2) gene to the susceptibility of chronic hepatitis B, and to analyze the frequencies of IL-2 gene polymorphisms and the HBV-DNA copies in patients with chronic hepatitis B.</p><p><b>METHODS</b>Two single nucleotide polymorphisms of IL-2 gene promoter -385T/G and +114T/G at exon one were analyzed in 155 patients with chronic hepatitis B and in 170 age- and sex-matched controls from a Chinese population. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) strategy and DNA sequencing were used, and the serum HBV DNA in these patients was determined by real-time PCR.</p><p><b>RESULTS</b>There were no differences in the distributions of IL-2 gene +114T/G polymorphism in the patient group and the controls, but their IL-2 gene -385T/G polymorphisms were significantly different (P less than 0.05). The relative risk of being chronic hepatitis B victims with T allele was 1.490 times of those with G allele (OR=1.490, 95% CI: 1.085-2.046). The association between the genotype of IL-2 gene polymorphisms and HBV-DNA copies showed that the frequency of -385G allele carriers in high HBV-DNA copy group was closer than that in low HBV-DNA copy group (chi2=6.051, P=0.014).</p><p><b>CONCLUSIONS</b>IL-2 gene -385T/G polymorphism is associated with chronic hepatitis B and G allele is an important genetic susceptibility gene for chronic hepatitis B. In IL-2 gene -385G allele carriers the risk of increasing HBV-DNA copies may be related to the pathogenesis of chronic hepatitis B.</p>

A dynamic observation on serum cytokine and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer / 中华预防医学杂志

<p><b>OBJECTIVE</b>To study the changes of serum interleukin-2 (IL-2), interleukin-8 (IL-8) and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer, and to probe the relationship between the levels of IL-2, IL-8, IgG, IgA and IgM and the progress of cancer.</p><p><b>METHODS</b>The serum levels of IL-2 and IL-8 were detected by enzyme-linked immunosorbent assay for 72 case of primary esophageal cancer, 68 advanced esophageal cancer and 120 healthy controls, and the level of immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer was dynamically observed.</p><p><b>RESULTS</b>The IL-2 level in patients with early esophageal cancer [(1.69 +/- 0.53) ng/ml] or late esophageal cancer [(1.11 +/- 0.60) ng/ml] was lower than the control group [(2.78 +/- 0.51) ng/ml] (P < 0.01), the late esophageal cancer group was lower than early esophageal cancer group (P < 0.05). The level of IL-8 in patients with early esophageal cancer [(85.48 +/- 6.14) ng/L] or late esophageal cancer [(121.41 +/- 6.22) ng/L] was much higher than the control group [(54.48 +/- 12.20) ng/L] (P < 0.01), the late esophageal cancer group was much higher than early esophageal cancer group (P < 0.01); There was correlation between the levels of IL-2 and IL-8 and the worsen-extent of the tumour in patients with early esophageal cancer or late esophageal cancer. But the level of IgG [(12.23 +/- 2.50) g/L], IgM [(1.60 +/- 0.80) g/L] in the patients with esophageal cancer compared with the level of IgG [(11.65 +/- 3.70) g/L], IgM [(1.46 +/- 0.71) g/L] in the health control group have no significant difference (P > 0.05), the level of IgA [(3.50 +/- 1.10) g/L] in patients with esophageal cancer Compared with the control group [(1.88 +/- 1.08) g/L] has significant difference (P < 0.01), and along with the worsen-extent of the tumor in patients the level of IgA has the increased tendency.</p><p><b>CONCLUSION</b>The IL-8 might accelerate the pathogenesis of esophageal cancer, and the IL-2 might restrain. The positive correlation between the level of IgA and the patients with esophageal cancer is observed in this study; the immune maladjustment of IL-2, IL-8 and IgA might be correlative to esophageal cancer, and the IL-2, IL-8 and IgA levels might be an available index for the severity of esophageal cancer, Which may be of some help for clinic practitioners to judge the progress, curative effect and prognosis of the cancer.</p>

Role and Clinical Significance of Myeloid Differentiation Protein-2 in Endotoxin Signal Transduction / 实用儿科临床杂志

Myeloid differentiation protein-2(MD-2)can separately and simultaneously bind lipopolysaccharide(LPS)and toll-like receptor 4(TLR4)has been shown to play critical roles in mediated recognition responses to LPS by TLR4 and signal transduction induced by LPS.MD-2 can be bound by LPS,not TLR4.The cells have no responsiveness or weak responsiveness to LPS without MD-2.MD-2 can be secreted into blood plasma,formed soluble MD-2 and remotely regulated cells that contained TLR4 without MD-2.MD-2 has been shown to play important roles in endotoxin signal transduction.MD-2 is a small molecular,short nucleic acid fragment,easily regulated should become a new potential anti-inflammatory target.